The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Characterization of the Heparin-Binding Properties of Human Clusterin
Abstract
Clusterin is a highly conserved mammalian glycoprotein which has been predicted to contain heparin-binding sites. We tested this prediction by studying the interactions between heparin and clusterin using ELISA and heparin affinity chromatography methodologies. Two forms of biotinylated heparin were used in ELISA: heparin which had been directly biotinylated with a biotin-N-hydroxysuccinimide ester and heparin which had been activated using epichlorohydrin and 1,6-diaminohexane prior to biotinylation. Both gave dose-dependent increases in ELISA signal with increasing concentrations of biotinylated heparin, with the latter giving signals an order of magnitude greater than the former. There was a dose-dependent increase in the ELISA signal from bound biotinylated heparin with increasing concentrations of plate-bound clusterin. The apparent affinity constant for binding of biotinylated heparin to plate-bound clusterin at pH 6.0 was estimated as 0.06 +/- 0.02 microM. Unlabeled heparin blocked the binding of biotinylated heparin to clusterin over a concentration range similar to that of the binding of biotinylated heparin to plate-bound clusterin. The binding of biotinylated heparin to clusterin was independent of the presence or absence of Ca2+. The binding of biotinylated heparin to plate-bound clusterin increased with decreasing pH over the range 5.5-8.0 and was characterized by an apparent pKa of 6.9. Clusterin in human serum bound to heparin-Sepharose at pH 6.0 but not at pH 7.4. Dot-blot experiments showed that one of the polypeptide chains of clusterin which had been reduced and alkylated under denaturing conditions bound to heparin-Sepharose. This chain was identified as the alpha chain from its N-terminal amino acid sequence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteins like TIMP3, clusterin, and vitronectin, which normally interact with sulfated glycosaminoglycans (GAGs) (37-39)”
From Drusen proteome analysis: an approach to the etiology of age-related macular degeneration (2002) · cites this paper as [38]
Citations
Cites
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Blaschuk, O., Burdzy, K., & Fritz, I. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32238-5 · Cited by 401
Murphy, B. F., Kirszbaum, L., Walker, I. D., & d'Apice, A. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113531 · Cited by 313
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Åkesson, P., Sjöholm, A. G., & Björck, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1081 · Cited by 268
Jenne, D. E., Lowin, B., Peitsch, M. C., Böttcher, A., Schmitz, G., & Tschopp, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99123-4 · Cited by 266
Margalit, H., Fischer, N., & Ben-Sasson, S. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36503-2 · Cited by 247
Kirszbaum, L., Sharpe, J. A., Murphy, B., d'Apice, A. J., Classon, B., Hudson, P., & Walker, I. D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03430.x · Cited by 238
Laboratory techniques in biochemistry and molecular biology
Gordon, H. (1976) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(76)90358-3 · Cited by 220
Tschopp, J., Chonn, A., Hertig, S., & French, L. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2159 · Cited by 190
Research works printed but not linked: 27
- de Silva H. V., 1990, Biochemistry 29, 5380−5389
- Kounnas M. Z., 1995, J. Biol. Chem., 270
- Reddy K. B., 1996, Biochemistry 35, 6157−6163
- Reddy K. B., 1996, Biochemistry 35, 309−314
- Harmony J. A. K., 1995, in Clusterin: Role in Vertebrate Development, Function and Development
- McDonald J. F., 1997, Biochemistry 36, 7464−7473
- Wilson M. R., 1991, Biochem. Biophys. Res. Commun. 177, 985−990
- Jordan-Starck T. C., 1990, Curr. Opin. Lipidol., 3, 85
- Rost B., 1994, Comput. Appl. Biosci., 10, 60
- Humphreys D., 1997, Biochemistry 36, 15233−15243
- Easterbrook-Smith S. B., 1988, Mol. Immunol. 25, 1331−1337
- Zou S., 1992, Comp. Biochem. Physiol. 103B, 889−895
- Harlow, E., and Lane, D. (1988) InAntibodies: A Laboratory Manual, pp 65−68, Cold Spring Harbor Laboratory Press, New York.
- Li X. A., 1994, Biochim. Biophys. Acta, 120
- Jenne D. E., 1989, Proc. Natl. Acad. Sci. U.S.A. 86, 7123−7127
- Foxall C., 1995, Anal. Biochem. 231, 366−373
- Weber P., 1995, J. Biol. Chem., 270
- Stearns N. A., 1997, Anal. Biochem. 247, 348−356
- Barrow R. T., 1994, J. Biol. Chem., 269
- Multhaup G., 1995, J. Mol. Recognit., 8
- Gigli M., 1992, Biochemistry 31, 5996−6003
- Jenne D. E., 1992, Trends Biochem. Sci. 17, 154−159
- James, R. W. (1995) inClusterin: Role in Vertebrate Development,Function and Development(Harmony, J. A. K., Ed.), pp 13−32, R. G. Landes Co., Austin, TX.
- Moy F. J., 1997, Biochemistry 36, 4782−4791
- Back T., 1994, Stroke 25, 494−500
- Abbreviations, transforming growth factor β
- Lakins M., 1997, Switzerland
Cited by
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins
Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B., & Wilson, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6875 · Cited by 455
Self-citationClusterin is a secreted mammalian chaperone
Wilson, M. R., & Easterbrook-Smith, S. B. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01534-0 · Cited by 378
Self-citationClusterin/Apolipoprotein J in human aging and cancer
Trougakos, I. P., & Gonos, E. S. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00041-9 · Cited by 376
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
Gerritsen, H. E., Robles, R., Lämmle, B., & Furlan, M. (2001) · Blood · doi:10.1182/blood.v98.6.1654 · Cited by 363
Metadata
- Authors
- Pankhurst, G. J., Bennett, C. A., & Easterbrook-Smith, S. B.
- Affiliations
- The University of Sydney (AU)
- Department of Biochemistry University of Sydney, Sydney NSW 2006, Australia
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-03-20
- Volume
- 37
- Issue
- 14
- Pages
- 4823-4830
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2081747645
- Cited by
- 40
- References
- 21
- Citations by year
- 2023: 2 · 2022: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 3 · 2012: 1
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Clusterin in disease pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- clusterin, heparin binding, glycoproteins, heparin-binding site, binding affinity, pH dependence, calcium independence, alpha chain, heparin-Sepharose, human serum
- MeSH terms
- Biotin, Calcium, Enzyme-Linked Immunosorbent Assay, Glycoproteins, Heparin, Humans, Hydrogen-Ion Concentration, Protein Binding, Sepharose, Molecular Chaperones, Clusterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of the Heparin-Binding Properties of Human Clusterin. https://app.cochat.ai/papers/10.1021/bi972367v
- The paper
- Pankhurst, G. J., Bennett, C. A., & Easterbrook-Smith, S. B. (1998). Characterization of the Heparin-Binding Properties of Human Clusterin. Biochemistry. https://doi.org/10.1021/bi972367v
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.